FDA Expands Use of Weight-Loss Drug to Adolescents

(MedPage Today) -- The FDA approved a supplemental indication for phentermine/topiramate extended-release capsules (Qsymia) for chronic weight management in adolescents ages 12 and older with obesity, defined as a body mass index (BMI) in the 95th...
Source: MedPage Today Public Health - Category: American Health Source Type: news